Valuation Glenmark Pharmaceuticals Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. 00:15:53 2026-09-02 EDT			5-day change	1st Jan Change
2,451.25 ^INR	-0.53%		+0.47%	+20.41%

08-19	Glenmark Pharmaceuticals Limited Receives U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg (50 Mcg)/Spray	CI
08-03	Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	124,718	131,124	270,463	434,866	601,567	697,149	-	-
Change	-	5.14%	106.27%	60.79%	38.33%	15.89%	-	-
Enterprise Value (EV) ¹	150,223	162,699	263,786	442,540	595,740	660,658	649,146	639,058
Change	-	8.3%	62.13%	67.76%	34.62%	10.9%	-1.74%	-1.55%
P/E	13.2x	44.1x	-18x	41.5x	44.2x	30x	25x	22.7x
PBR	1.37x	1.38x	3.45x	4.91x	5.72x	5.51x	4.57x	3.88x
PEG	-	-0.6x	0x	-0x	1.5x	0.4x	1.2x	2.28x
Capitalization / Revenue	1.01x	1.01x	2.29x	3.26x	3.54x	4.15x	3.73x	3.35x
EV / Revenue	1.22x	1.25x	2.23x	3.32x	3.51x	3.93x	3.47x	3.07x
EV / EBITDA	6.47x	7.14x	22.1x	18.8x	13x	18.3x	15.1x	13.4x
EV / EBIT	8.19x	9.76x	43x	23.7x	14.9x	22.1x	18.1x	16.5x
EV / FCF	47.2x	923x	-22.7x	-28.1x	28.5x	39.7x	34.2x	29.6x
FCF Yield	2.12%	0.11%	-4.41%	-3.56%	3.5%	2.52%	2.92%	3.38%
Dividend per Share ²	2.5	2.5	2.5	2.5	2.5	3.82	4.02	3.75
Rate of return	0.57%	0.54%	0.26%	0.16%	0.12%	0.15%	0.16%	0.15%
EPS ²	33.4	10.53	-53.22	37.11	48.24	82.22	98.93	108.8
Distribution rate	7.49%	23.7%	-4.7%	6.74%	5.18%	4.65%	4.06%	3.45%
Net sales ¹	123,409	129,901	118,131	133,217	169,825	167,925	187,122	208,096
EBITDA ¹	23,203	22,784	11,953	23,514	45,724	36,102	42,870	47,723
EBIT ¹	18,336	16,671	6,134	18,654	39,989	29,950	35,801	38,801
Net income ¹	9,936	2,972	-15,017	10,471	13,619	23,110	27,707	29,641
Net Debt ¹	25,505	31,575	-6,677	7,674	-5,827	-36,491	-48,003	-58,091
Reference price ²	442.00	464.70	958.45	1,541.05	2,131.70	2,470.40	2,470.40	2,470.40
Nbr of stocks (in thousands)	282,168	282,168	282,188	282,188	282,201	282,201	-	-
Announcement Date	5/27/22	5/19/23	5/24/24	5/23/25	5/29/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	36.62x	6.9x	23.9x	0.86%	50.05B
OTSUKA HOLDINGS CO., LTD.	17.64x	2.21x	9.97x	1.47%	40.29B
ZYDUS LIFESCIENCES LIMITED	27.84x	3.97x	16.46x	0.58%	12.17B
CIPLA LIMITED	27.43x	3.33x	17.26x	0.92%	11.96B
KRKA, D. D.	18.95x	3.37x	11.73x	3.81%	9.25B
GEDEON RICHTER	9.61x	2.22x	5.73x	4.5%	7.62B
GLENMARK PHARMACEUTICALS LIMITED	30.16x	3.95x	18.37x	0.15%	7.36B
ONO PHARMACEUTICAL CO., LTD.	15.8x	2.07x	6.71x	3.19%	7.21B
Average	23.01x	3.50x	13.77x	1.94%	18.24B
Weighted average by Cap.	26.01x	4.21x	16.04x	1.47%